298 related articles for article (PubMed ID: 8004575)
1. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
Bash RO; Katz JA; Cash JV; Buchanan GR
Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
[TBL] [Abstract][Full Text] [Related]
2. Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia.
Aquino VM; Buchanan GR; Tkaczewski I; Mustafa MM
Med Pediatr Oncol; 1997 Mar; 28(3):191-5. PubMed ID: 9024515
[TBL] [Abstract][Full Text] [Related]
3. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.
Griffin TC; Buchanan GR
J Pediatr; 1992 Jul; 121(1):28-33. PubMed ID: 1625089
[TBL] [Abstract][Full Text] [Related]
4. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient.
Mullen CA; Buchanan GR
J Clin Oncol; 1990 Dec; 8(12):1998-2004. PubMed ID: 2230891
[TBL] [Abstract][Full Text] [Related]
5. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
6. Early discharge of low-risk febrile neutropenic children and adolescents with cancer.
Aquino VM; Tkaczewski I; Buchanan GR
Clin Infect Dis; 1997 Jul; 25(1):74-8. PubMed ID: 9243037
[TBL] [Abstract][Full Text] [Related]
7. Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.
Lehrnbecher T; Stanescu A; Kühl J
Infection; 2002 Jan; 30(1):17-21. PubMed ID: 11876510
[TBL] [Abstract][Full Text] [Related]
8. Early hospital discharge of children with fever and neutropenia: a prospective study.
Wacker P; Halperin DS; Wyss M; Humbert J
J Pediatr Hematol Oncol; 1997; 19(3):208-11. PubMed ID: 9201142
[TBL] [Abstract][Full Text] [Related]
9. Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia. A preliminary prospective trial.
Cohen KJ; Leamer K; Odom L; Greffe B; Stork L
J Pediatr Hematol Oncol; 1995 Nov; 17(4):325-30. PubMed ID: 7583388
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
[TBL] [Abstract][Full Text] [Related]
11. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
Hodgson-Viden H; Grundy PE; Robinson JL
BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
[TBL] [Abstract][Full Text] [Related]
12. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
[TBL] [Abstract][Full Text] [Related]
13. Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.
Campbell ME; Friedman DL; Dulek DE; Zhao Z; Huang Y; Esbenshade AJ
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115709
[TBL] [Abstract][Full Text] [Related]
14. Fever and neutropenia in children with malignant disease.
Roguin A; Kasis I; Ben-Arush MW; Sharon R; Berant M
Pediatr Hematol Oncol; 1996; 13(6):503-10. PubMed ID: 8940733
[TBL] [Abstract][Full Text] [Related]
15. Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia.
Klaassen RJ; Allen U; Doyle JJ
J Pediatr Hematol Oncol; 2000; 22(5):405-11. PubMed ID: 11037850
[TBL] [Abstract][Full Text] [Related]
16. Outcome of febrile neutropenic patients on granulocyte colony stimulating factor in a tertiary care hospital.
Osmani AH; Ansari TZ; Masood N; Ahmed B
Asian Pac J Cancer Prev; 2012; 13(6):2523-6. PubMed ID: 22938399
[TBL] [Abstract][Full Text] [Related]
17. Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
Innes HE; Smith DB; O'Reilly SM; Clark PI; Kelly V; Marshall E
Br J Cancer; 2003 Jul; 89(1):43-9. PubMed ID: 12838298
[TBL] [Abstract][Full Text] [Related]
18. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
19. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
[TBL] [Abstract][Full Text] [Related]
20. Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.
Villanueva MA; August KJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1829-33. PubMed ID: 27196265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
